|
Jan 8
|
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jan 8
|
AngioDynamics: Fiscal Q2 Earnings Snapshot
|
|
Jan 8
|
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
|
|
Jan 6
|
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
|
|
Oct 4
|
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
|
|
Oct 4
|
AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025
|
|
Oct 4
|
Q1 2025 AngioDynamics Inc Earnings Call
|
|
Oct 4
|
AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ...
|
|
Oct 3
|
Why AngioDynamics Stock Is Crashing Today
|
|
Oct 3
|
Here's Why You Should Add AngioDynamics Stock to Your Portfolio
|
|
Oct 3
|
AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates
|
|
Oct 3
|
AngioDynamics: Fiscal Q1 Earnings Snapshot
|
|
Oct 3
|
AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
|
|
Sep 30
|
New Strong Buy Stocks for September 30th
|
|
Sep 23
|
ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe
|
|
Sep 4
|
AngioDynamics Stock Falls Despite CE Mark for Auryon System
|
|
Sep 4
|
AngioDynamics wins EU CE mark for Auryon system to treat PAD
|
|
Sep 3
|
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
|
|
Sep 1
|
TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching
|
|
Aug 27
|
AngioDynamics (ANGO) Upgraded to Strong Buy: Here's Why
|